These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 8674902)
21. New frontiers in the management of type 2 diabetes. Mudaliar S Indian J Med Res; 2007 Mar; 125(3):275-96. PubMed ID: 17496356 [TBL] [Abstract][Full Text] [Related]
22. Effectiveness and safety of basal supported oral therapy with insulin glargine, in Japanese insulin-naive, type 2 diabetes patients, with or without microvascular complications: subanalysis of the observational, non-interventional, 24-week follow-up Add-on Lantus® to Oral Hypoglycemic Agents (ALOHA) study. Odawara M; Kadowaki T; Naito Y J Diabetes Complications; 2015; 29(1):127-33. PubMed ID: 25449981 [TBL] [Abstract][Full Text] [Related]
24. The intriguing effects of time to glycemic goal in newly diagnosed type 2 diabetes after short-term intensive insulin therapy. Cheng L; Xu M; Lin X; Tang J; Qi Y; Wan Y; Pan X; Chen X; Ren M; Yan L Endocr J; 2016 Aug; 63(8):739-46. PubMed ID: 27334121 [TBL] [Abstract][Full Text] [Related]
25. Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes. Paneni F; Lüscher TF Am J Med; 2017 Jun; 130(6S):S18-S29. PubMed ID: 28526186 [TBL] [Abstract][Full Text] [Related]
26. Pharmacological strategies to prevent macrovascular disease in NIDDM. Colwell JA Diabetes; 1997 Sep; 46 Suppl 2():S131-4. PubMed ID: 9285515 [TBL] [Abstract][Full Text] [Related]
27. Effect of intensive treatment on vascular and other complications of diabetes mellitus. Fonseca V Clin Cornerstone; 2004; 6(2):40-50. PubMed ID: 15628692 [TBL] [Abstract][Full Text] [Related]
28. Macrovascular and microvascular outcomes after beginning of insulin versus additional oral glucose-lowering therapy in people with type 2 diabetes: an observational study. Hall GC; McMahon AD; Carroll D; Home PD Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):305-13. PubMed ID: 22271442 [TBL] [Abstract][Full Text] [Related]
29. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Estacio RO; Jeffers BW; Gifford N; Schrier RW Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192 [TBL] [Abstract][Full Text] [Related]
30. Veterans Administration Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: II. Effects of aspirin and dipyridamole on atherosclerotic vascular disease rates. Colwell JA; Bingham SF; Abraira C; Anderson JW; Comstock JP; Kwaan HC; Nuttall F Diabetes Care; 1986; 9(2):140-8. PubMed ID: 3516608 [TBL] [Abstract][Full Text] [Related]
31. Macrovascular disease and hyperinsulinaemia. Robertson DA; Hale PJ; Nattrass M Baillieres Clin Endocrinol Metab; 1988 May; 2(2):407-24. PubMed ID: 3075899 [TBL] [Abstract][Full Text] [Related]
32. Intensive insulin therapy for Japanese patients with type 2 diabetes mellitus--results in the patients from single hospital. Toyoda M; Umezono T; Abe M; Kobayashi K; Kato M; Yoshino K; Kobayashi T; Miyauchi M; Yamamoto N; Kimura M; Maruyama M; Honma M; Yagame M; Suzuki D Tokai J Exp Clin Med; 2008 Jul; 33(2):95-9. PubMed ID: 21318975 [TBL] [Abstract][Full Text] [Related]
33. Long-term intensive insulin therapy for Japanese patients with type 2 diabetes mellitus. Umezono T; Toyoda M; Abe M; Kobayashi K; Kato M; Miyauchi M; Kobayashi T; Yamamoto N; Kimura M; Yagame M; Suzuki D Intern Med; 2008; 47(24):2109-15. PubMed ID: 19075534 [TBL] [Abstract][Full Text] [Related]
34. Refuting the UGDP conclusion that insulin treatment does not prevent vascular complications in diabetes. Kilo C; Williamson JR; Choi SC; Miller JP Adv Exp Med Biol; 1979; 119():307-11. PubMed ID: 495289 [No Abstract] [Full Text] [Related]
35. Legacy effects from DCCT and UKPDS: what they mean and implications for future diabetes trials. Murray P; Chune GW; Raghavan VA Curr Atheroscler Rep; 2010 Nov; 12(6):432-9. PubMed ID: 20652839 [TBL] [Abstract][Full Text] [Related]
36. Epidemiology and management of type 1 diabetes mellitus at the ain shams university pediatric hospital. Ismail NA; Kasem OM; Abou-El-Asrar M; El-Samahy MH J Egypt Public Health Assoc; 2008; 83(1-2):107-32. PubMed ID: 18992206 [TBL] [Abstract][Full Text] [Related]
37. Does intensive glycemic control for type 2 diabetes mellitus have long-term benefits for cardiovascular disease risk? Soldatos G; Cooper ME Nat Clin Pract Endocrinol Metab; 2009 Mar; 5(3):138-9. PubMed ID: 19190588 [TBL] [Abstract][Full Text] [Related]
38. Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes. Berard L; Antonishyn N; Arcudi K; Blunden S; Cheng A; Goldenberg R; Harris S; Jones S; Mehan U; Morrell J; Roscoe R; Siemens R; Vallis M; Yale JF Diabetes Ther; 2018 Apr; 9(2):501-519. PubMed ID: 29476414 [TBL] [Abstract][Full Text] [Related]
39. Impact of Intensive Glycemic Treatment on Diabetes Complications-A Systematic Review. Poonoosamy J; Lopes P; Huret P; Dardari R; Penfornis A; Thomas C; Dardari D Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37513978 [TBL] [Abstract][Full Text] [Related]
40. Intensive Glycemic Control and Macrovascular Disease in Type 2 Diabetes - A Report on the 44th Annual EASD Meeting, Rome, Italy, September 2008. Rönnemaa T Rev Diabet Stud; 2008; 5(3):180-3. PubMed ID: 19099091 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]